Carmen L. Charlton

TL;DR: In this article, a surrogate virus neutralization test (sVNT) was proposed for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology tests.

TL;DR: It is shown that Pseudomonas aeruginosa minor pilins prime pilus assembly and traffic the pilus-associated adhesin and anti-retraction protein PilY1 to the cell surface, expanding the structural and functional similarities between the T4P and T2S systems.

TL;DR: The article provides guidance to a rapidly changing field of diagnostics and outlines the epidemiology and clinical impact of acute respiratory viral infections, including preferred methods of specimen collection and current methods for diagnosis and characterization of viral pathogens causing acute respiratory tract infections.

TL;DR: A head-to-head assessment of enzyme immunoassays (EIAs) and point-of-care lateral flow assays (POCTs) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies found overall specificity of EIAs was good; however, overall sensitivity of POCTs was low, and cross-reactivity with other respiratory viruses was observed.

TL;DR: Both systems performed with high accuracy when evaluated solely on Food and Drug Administration-approved organisms for each database and a user-based assessment of the 2 instruments revealed an overall preference for the Vitek MS instrument.